|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
First published online 7 October 2008
doi: 10.1242/jcs.036798
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Research Article |
University of Dundee, School of Life Sciences, Dow Street, Dundee DD1 5EH, UK
* Author for correspondence (e-mail: j.g.williams{at}dundee.ac.uk)
Accepted 31 July 2008
| Summary |
|---|
|
|
|---|
Key words: Cbl, SH2 domain, Dictyostelium, STAT, DIF, PTP
| Introduction |
|---|
|
|
|---|
Cbl proteins contain a phosphotyrosine binding domain [also known as a tyrosine kinase binding (TKB) domain] at their N terminus, which comprises a four helix-bundle, a Ca2+ binding EF-hand and a highly variant SH2 domain (Meng et al., 1999
; Thien and Langdon, 2001
). The TKB domain is connected, via a conserved linker region, to a C3HC4 type RING finger. The RING finger has E3 ligase activity (Joazeiro et al., 1999
; Levkowitz et al., 1999
) and directs the mono-ubiquitylation of activated RTKs. This promotes RTK endocytosis and endosomal sorting of RTKs for lysosomal degradation (de Melker et al., 2001
; Dikic and Giordano, 2003
; Levkowitz et al., 1998
; Longva et al., 2002
). In addition to their role in RTK signal termination, Cbl proteins are also involved in the mediation of positive RTK signalling to downstream targets by acting as multi-domain adaptors (Swaminathan and Tsygankov, 2006
).
Cbl proteins in which the RING finger and/or linker region have been mutated or deleted, which results in altered Cbl function, are oncogenic in animal models (Andoniou et al., 1994
; Bonita et al., 1997
; Langdon et al., 1989
; Thien and Langdon, 1997b
; Thien and Langdon, 2001
). It is believed that they act as dominant-negatives by competing with the wild-type protein for binding sites (Bonita et al., 1997
; Thien and Langdon, 1997a
). Recently the first human oncogenic CBL form has been identified, in an acute myeloid leukaemia patient, underlining the attractiveness of CBL proteins as potential therapeutic targets (Sargin et al., 2007
). There are Cbl orthologues in C. elegans (Yoon et al., 1995
) and in D. melanogaster (Meisner et al., 1997
), where they play important roles in developmental signalling. We have identified a Cbl-like protein in Dictyostelium, a facultative multicellular organism that possesses a small but diverse set of SH2 domain proteins.
Dictyostelium cells exist during vegetative growth as solitary amoebae but when their bacterial food source is exhausted they aggregate together in response to pulses of cAMP emitted from the centre of the aggregation territory. Some of the cells within the aggregate differentiate into prespore cells and synthesise and secrete a chlorinated hexaphenone, DIF-1 (henceforth termed DIF), that directs uncommitted cells in the population to become prestalk cells (Kay and Thompson, 2001
). Addition of DIF to cells directs nuclear translocation of a GATA and two bZIP transcription factors and induces prestalk-specific gene expression (Huang et al., 2006
; Keller and Thompson, 2008
; Thompson et al., 2004
; Zhukovskaya et al., 2006
). DIF also induces tyrosine phosphorylation of a signal transducer and activator of transcription (STAT) protein, STATc, at a site near its C terminus (Fukuzawa et al., 2001
). This causes STATc to homodimerise, via reciprocal SH2 domain-phosphotyrosine interactions, and to accumulate in the nucleus. The tyrosine kinase that phosphorylates STATc is unknown but the rise in tyrosine phosphorylation of STATc is, in part at least, caused by DIF-induced inhibition of PTP3, the tyrosine phosphatase that dephosphorylates STATc (Araki et al., 2008
). Understanding the regulation of PTP3 activity is therefore key to understanding STATc activation and we present evidence that the Dictyostelium Cbl homologue, CblA, upregulates STATc tyrosine phosphorylation via an inhibitory effect on PTP3 accumulation.
| Results |
|---|
|
|
|---|
|
Analysis of cblA expression and intracellular localisation
RT-PCR shows that the cblA mRNA is present at a relatively low level in growing cells and accumulates during the first few hours of development, to reach a plateau during aggregation (Fig. 2A). An antibody was generated and purified using a C terminus proximal CblA peptide sequence. Although the antibody cannot be employed for immunostaining or immunoprecipitation it is usable in western transfer. At least up to the slug stage, the latest stage analysed, the CblA protein accumulation pattern is quite similar to the RNA accumulation pattern (Fig. 2B).
|
|
|
cblA– cells grow at a normal rate and develop to the first finger stage correctly. The migratory cblA– slugs that are formed are, however, very variable in size and often fragment along their length (Fig. 5A). Also, cblA– culminants produced when migrating slugs enter terminal differentiation have either a much reduced or no basal disc. This is apparent from phase-contrast images (Fig. 5A) and is confirmed by the absence and/or reduction of cells expressing ecmB:lacZ (a stalk and basal disc marker) in the position normally occupied by the basal disc (Fig. 5B). Presumably as a consequence of this defect, the fruiting bodies that are formed frequently collapse on to the substratum to form a tangled mass. These two phenotypic features, slugs that fragment along their length and a much-reduced basal disc, are also characteristic of mutants in DIF biosynthesis and DIF signalling (Keller and Thompson, 2008
; Saito et al., 2008
). (NB For the cblA– clone used throughout this study, strain JGW-JL-1, there is an apparent difference with the previous studies; the basal disc formation defect is seen only if slugs are allowed to migrate away from the site of aggregation. However, there is clonal variation and a second disruptant strain, JGW-JL-2 behaves in the same way as the published mutants, i.e. there is little or no outer basal disc in culminants whether or not they derive from newly formed or migratory slugs.)
|
|
|
Stress-inducible STATc tyrosine phosphorylation is normal in the cblA– strain
STATc is activated by hyper-osmotic stress with similar initial kinetics as with DIF but to a higher peak level and for a much longer period of time (Araki et al., 2003
). It was therefore of interest to determine whether CblA also regulates the stress response. Cells, at 4 hours of development were either left untreated or incubated with 200 mM sorbitol for 15 minutes. Sorbitol treatment induced an equivalent level of STATc tyrosine phosphorylation in control and cblA– cells (Fig. 7C). Thus CblA does not regulate the stress-responsivess of STATc.
CblA regulates STATc tyrosine phosphorylation via an effect on PTP3
The tyrosine phosphorylation status of STATc is determined by the balance of activity between an unidentified tyrosine kinase and the PTP3 tyrosine phosphatase (Araki et al., 2008
). Thus one potential explanation for the reduced DIF-induced tyrosine phosphorylation of STATc in the cblA– strain is that CblA acts as a negative regulator of PTP3. This possibility was investigated using the cblA– strain. The concentration of PTP3 was assessed using an antibody directed against an internal PTP3 peptide. When used in western transfer of either PTP3:myc or PTP3
CS:myc transformant lysates, the antibody detects bands of the expected sizes of the myc-tagged proteins as well as a band of 40 kDa (Fig. 8A). The higher mobility bands are detected when the blot is re-probed with a myc antibody but the 40 kDa protein is not (data not shown).
|
PTP3 seems to be highly susceptible to proteolytic degradation and the 40 kDa species is we believe an internal fragment derived from PTP3. The evidence for this comes from comparing the amount of 40 kDa protein in control, untransformed cells and in cells over-expressing PTP3:myc (Fig. 8B). Over-expressing clones have a much higher level of 40 kDa protein than the non-transformed parental strain; averaging three independent experiments there was an approximate 20-fold excess of 40 kDa protein in PTP3:myc-expressing cells. Indeed, in non-transformed cells, there is no detectable full-length PTP3 protein, presumably indicating that, in the case of the endogenous PTP3 protein, there is complete proteolysis. This conclusion is supported by similar observations using an antibody raised against recombinant PTP3 (Gamper et al., 1996
) and our unpublished studies using two internal peptides as immunogens in which all three antibodies failed to detect full-length endogenous PTP3.
In the cblA– strain the 40 kDa PTP3-derived fragment is present at a much higher relative level and this holds true whether or not DIF is present (Fig. 8C). In four such independent western transfer analyses there was on average eight times more 40 kDa protein in cblA– cells than in the control cells. Given the paradigmatic mechanism of action of Cbl proteins, this result suggested that CblA may constitutively downregulate PTP3 by a direct interaction. In order to determine whether there is a physical linkage between CblA and PTP3, their differently tagged forms were assayed for co-immunoprecipitation. No interaction was detectable (data not shown). This negative result is, however, difficult to interpret as it could simply indicate that binding of CblA to PTP3 leads to very rapid degradation of PTP3 via the proteasome. Unfortunately, concentrations as high as 100 µM of the commonly used proteasome inhibitor clasto-lactacystin β-lactone had no discernible effect on PTP3. This is in agreement with a study by Mohanty et al. (Mohanty et al., 2001
), who also tested two other commonly used proteasome inhibitors: MG132 and MG262. They concluded that the lack of effect was due to restricted permeability of the drugs. This technical impasse precluded further pharmacological investigation of this issue. We were also unable to use a genetic approach to the problem, by expressing intact and RING finger deleted forms of CblA in cblA-null cells, because over-expression of full-length CblA proved deleterious to the cells.
| Discussion |
|---|
|
|
|---|
Regulation of multicellular development by CblA
Overt phenotypes caused by the cblA– mutation first become manifest at the slug stage. The slugs fragment along their length and basal disc formation is defective. These are also characteristic features of mutants that are involved in DIF signalling but, unlike the dimA-, dimB- and mybE-null mutants (Fukuzawa et al., 2006
; Huang et al., 2006
; Thompson et al., 2004
; Zhukovskaya et al., 2006
) ecmA remains DIF inducible in the cblA– strain. Thus it is possible to genetically uncouple the morphological phenotypes, slug fragmentation and aberrant basal disc formation, from the defective ecmA induction phenotype.
In a cblA– strain DIF induces STATc tyrosine phosphorylation with normal kinetics but the magnitude of the response is approximately three times lower than in control cells. The proto-oncogene Cbl has been shown to be involved in regulating STAT tyrosine phosphorylation in metazoan cells (Blesofsky et al., 2001
; Goh et al., 2002
; Rathinam et al., 2008
; Ueno et al., 1997
; Wang et al., 2002
). These effects are mediated by modulation of tyrosine kinase activity but our evidence suggests that CblA exerts its effect by acting upon the accumulation of PTP3 protein tyrosine phosphatase. In the cblA– strain there is an increase in concentration of a 40 kDa protein fragment that is derived from PTP3. This could, in principle, be due to the direct binding of CblA to PTP3, but it was not possible to detect an interaction by co-immunoprecipitation. Also, PTP3 is not detectably tyrosine phosphorylated, when assayed by either isotopic labelling (Gamper et al., 1996
) or using a phosphotyrosine antibody (our unpublished results). There could, therefore, be an intermediary adaptor protein. Alternatively, proteolytic cleavage of PTP3 to liberate the 40 kDa sub-fragment may reveal a cryptic tyrosine phosphorylation site but the fact that the PTP3 antibody does not immunoprecipitate the 40 kDa species (our unpublished data) prevented testing of this possibility.
A signalling relationship between the STATc and DimB DIF induction pathways?
Combining the information for both the known DIF signalling pathways leads us to propose the scheme presented in Fig. 9. The two pathways have separate effects on, respectively, ecmA gene transcription and STATc activation but they exert a common effect on the two morphogenetic processes: the maintenance of slug integrity and basal disc formation. In the case of DimB we propose a positive effect on the transcription of ecmA and genes involved in the two morphogenetic processes. In the case of PTP3 we propose a negative effect on STATc and on the two morphogenetic processes, with DIF and CblA both acting to downregulate PTP3. There is, however, a significant difference in that DIF is a concentration-dependent, regulative inducer of STATc activation whereas CblA seems to act constitutively.
|
CblA and the stress induced STATc activation pathway
CblA appears not to be involved in the STATc stress pathway, because this response is unaffected in the cblA– mutant. Thus the stress and DIF activation pathways can be uncoupled genetically. We believe that the insensitivity of the stress response to CblA mutation reflects the fact that, upon stress treatment, serine-threonine phosphorylation of PTP3 is much increased relative to DIF treatment, and the inhibition of PTP3 enzymatic activity is greater (Araki et al., 2008
) (our unpublished data). Thus we suggest that the excess PTP3 that accumulates in cblA– cells is not completely inhibited by DIF-induced phosphorylation but is completely inhibited by stress-induced phosphorylation (Fig. 9).
| Materials and Methods |
|---|
|
|
|---|
Reverse transcriptase PCR
Total cell RNA was prepared using the Mini RNAeasy kit (Qiagen) with on-column DNA digestion. RT-PCR was performed with the TitaniumTMOne-Step RT-PCR kit (Clontech). The cblA primers were: fwd960 5'-AAA CTC AAA GAT ATT CAG TGG TTT CAT A-3' and rev1926 5'-TGA ACA TAA TGAACA ACA ACT TAA ATG A-3'. IG7 is present at a relatively constant level throughout Dictyostelium development, so reverse transcriptase PCR with IG7 primers was used as loading control. The IG7 primers were: rev5'-TTC CCT TTA GAC CTA TGG ACC TTA GCG-3'and fwd5'-TTA CAT TTA TTA GAC CCG AAA CCA AGC G-3'. ecmA reverse transcriptase PCR was performed as described previously (Zhukovskaya et al., 2006
). For quantitative PCR (qPCR) analysis, RNA was made as described above. cDNA synthesis was performed with the ImProm-IITM Reverse Transcription System (Promega).
Gene disruption and generation of CblA and PTP3 expression constructs
The cblA gene was cloned and disrupted in E. coli by random insertion of a transposon containing a blasticidin resistance cassette (Abe et al., 2003
). Clones were screened by PCR and a disruptant in the EF-hand sequence was selected (position 880 bp). It was used to generate disruptants of the cblA gene in Dictyostelium and these occurred at a frequency of about 10%. All expression constructs were generated using the semi-constitutive actin 15 promoter to direct transcription, and cells were selected to high copy number using a G418 resistance cassette contained within the vector. A GFP expression construct was generated by cloning GFP at the N terminus of CblA. All the PTP3 expression constructs used are described by Araki et al. (Araki et al., 2008
).
Immunochemistry
Polyclonal rabbit antisera were generated against the CblA peptide RSRITRVINIFKS and against the PTP3 peptide GIRSLSSPSKRRS. These peptides contained a non-coded cysteine residue at, respectively, their N and C termini, and they were coupled to Affi-gel (Bio-Rad) in order to purify the antibody. Other antibodies used were: GSK3 antibody (Millipore), total anti STATc (7H3) and anti-phospho-Tyr922-STATc (CP22).
For western transfer, proteins were separated on pre-cast 4-12% polyacrylamide gels (Novex) and electro-transferred to nitrocellulose membranes. Membranes were blocked with 5% skimmed milk in TBS-Tween (Tris-buffered saline, 0.05% Tween 20) for 30 minutes, then incubated with primary antibody overnight at 4°C. Signals were detected using HRP-a-conjugated goat anti-mouse and goat anti-rabbit antibodies (Bio-Rad) with a chemiluminescent detection system (Pierce). To quantify changes in the proportion of the 40 kDa protein and tyrosine phosphorylated STATc, image quantification was performed using the NIH Image 6.16/ppc software. Differences in loading were normalised using the general STATc antibody, 7H3.
Immunostaining for DimB and monolayer assay of ecmA induction by DIF were performed as described previously (Zhukovskaya et al., 2006
).
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
Abe, T., Langenick, J. and Williams, J. G. (2003). Rapid generation of gene disruption constructs by in vitro transposition and identification of a Dictyostelium protein kinase that regulates its rate of growth and development. Nucleic Acids Res. 31, e107.
Andoniou, C. E., Thien, C. B. and Langdon, W. Y. (1994). Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J. 13, 4515-4523.[Medline]
Araki, T., Tsujioka, M., Abe, T., Fukuzawa, M., Meima, M., Schaap, P., Morio, T., Urushihara, H., Katoh, M., Maeda, M. et al. (2003). A STAT-regulated, stress-induced signalling pathway in Dictyostelium. J. Cell Sci. 116, 2907-2915.
Araki, T., Langenick, J., Gamper, M., Firtel, R. A. and Williams, J. G. (2008). Evidence that DIF-1 and hyper-osmotic stress activate a Dictyostelium STAT by inhibiting a specific protein tyrosine phosphatase. Development 135, 1347-1353.
Blesofsky, W. A., Mowen, K., Arduini, R. M., Baker, D. P., Murphy, M. A., Bowtell, D. D. and David, M. (2001). Regulation of STAT protein synthesis by c-Cbl. Oncogene 20, 7326-7333.[CrossRef][Medline]
Bonita, D. P., Miyake, S., Lupher, M. L., Jr, Langdon, W. Y. and Band, H. (1997). Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor alpha signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity. Mol. Cell. Biol. 17, 4597-4610.[Abstract]
Cuff, J. A. and Barton, G. J. (2000). Application of multiple sequence alignment profiles to improve protein secondary structure prediction. Proteins 40, 502-511.[CrossRef][Medline]
de Melker, A. A., van der Horst, G., Calafat, J., Jansen, H. and Borst, J. (2001). c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route. J. Cell Sci. 114, 2167-2178.
Dikic, I. and Giordano, S. (2003). Negative receptor signalling. Curr. Opin. Cell Biol. 15, 128-135.[CrossRef][Medline]
Dikic, I. and Schmidt, M. H. (2007). Malfunctions within the Cbl interactome uncouple receptor tyrosine kinases from destructive transport. Eur. J. Cell Biol. 86, 505-512.[CrossRef][Medline]
Dingermann, T., Reindl, N., Werner, H., Hildebrandt, M., Nellen, W., Harwood, A., Williams, J. and Nerke, K. (1989). Optimization and in situ detection of Escherichia coli beta-galactosidase gene expression in Dictyostelium discoideum. Gene 85, 353-362.[CrossRef][Medline]
Eichinger, L., Pachebat, J. A., Glockner, G., Rajandream, M. A., Sucgang, R., Berriman, M., Song, J., Olsen, R., Szafranski, K., Xu, Q. et al. (2005). The genome of the social amoeba Dictyostelium discoideum. Nature 435, 43-57.[CrossRef][Medline]
Fukuzawa, M., Araki, T., Adrian, I. and Williams, J. G. (2001). Tyrosine phosphorylation-independent nuclear translocation of a Dictyostelium STAT in response to DIF signaling. Mol. Cell 7, 779-788.[CrossRef][Medline]
Fukuzawa, M., Zhukovskaya, N. V., Yamada, Y., Araki, T. and Williams, J. G. (2006). Regulation of Dictyostelium prestalk-specific gene expression by a SHAQKY family MYB transcription factor. Development 133, 1715-1724.
Gamper, M., Howard, P. K., Hunter, T. and Firtel, R. A. (1996). Multiple roles of the novel protein tyrosine phosphatase PTP3 during Dictyostelium growth and development. Mol. Cell. Biol. 16, 2431-2444.[Abstract]
Goh, E. L., Zhu, T., Leong, W. Y. and Lobie, P. E. (2002). c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription. Endocrinology 143, 3590-3603.
Huang, E., Blagg, S. L., Keller, T., Katoh, M., Shaulsky, G. and Thompson, C. R. (2006). bZIP transcription factor interactions regulate DIF responses in Dictyostelium. Development 133, 449-458.
Joazeiro, C. A., Wing, S. S., Huang, H., Leverson, J. D., Hunter, T. and Liu, Y. C. (1999). The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286, 309-312.
Kay, R. R. and Thompson, C. R. (2001). Cross-induction of cell types in Dictyostelium: evidence that DIF-1 is made by prespore cells. Development 128, 4959-4966.
Keller, T. and Thompson, C. R. (2008). Cell type specificity of a diffusible inducer is determined by a GATA family transcription factor. Development 135, 1635-1645.
Langdon, W. Y., Hartley, J. W., Klinken, S. P., Ruscetti, S. K. and Morse, H. C., 3rd (1989). v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl. Acad. Sci. USA 86, 1168-1172.
Levkowitz, G., Waterman, H., Zamir, E., Kam, Z., Oved, S., Langdon, W. Y., Beguinot, L., Geiger, B. and Yarden, Y. (1998). c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12, 3663-3674.
Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A. et al. (1999). Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell 4, 1029-1040.[CrossRef][Medline]
Liu, B. A., Jablonowski, K., Raina, M., Arce, M., Pawson, T. and Nash, P. D. (2006). The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol. Cell 22, 851-868.[CrossRef][Medline]
Longva, K. E., Blystad, F. D., Stang, E., Larsen, A. M., Johannessen, L. E. and Madshus, I. H. (2002). Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies. J. Cell Biol. 156, 843-854.
Meisner, H., Daga, A., Buxton, J., Fernandez, B., Chawla, A., Banerjee, U. and Czech, M. P. (1997). Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell. Biol. 17, 2217-2225.[Abstract]
Meng, W., Sawasdikosol, S., Burakoff, S. J. and Eck, M. J. (1999). Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase. Nature 398, 84-90.[CrossRef][Medline]
Mohanty, S., Lee, S., Yadava, N., Dealy, M. J., Johnson, R. S. and Firtel, R. A. (2001). Regulated protein degradation controls PKA function and cell-type differentiation in Dictyostelium. Genes Dev. 15, 1435-1448.
Pang, K. M., Lynes, M. A. and Knecht, D. A. (1999). Variables controlling the expression level of exogenous genes in Dictyostelium. Plasmid 41, 187-197.[CrossRef][Medline]
Rathinam, C., Thien, C. B., Langdon, W. Y., Gu, H. and Flavell, R. A. (2008). The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells. Genes Dev. 22, 992-997.
Saito, T., Kato, A. and Kay, R. R. (2008). DIF-1 induces the basal disc of the Dictyostelium fruiting body. Dev. Biol. 317, 444-453.[CrossRef][Medline]
Sargin, B., Choudhary, C., Crosetto, N., Schmidt, M. H., Grundler, R., Rensinghoff, M., Thiessen, C., Tickenbrock, L., Schwable, J., Brandts, C. et al. (2007). Flt3-dependent transformation by inactivating c-Cbl mutations in AML. Blood 110, 1004-1012.
Singleton, C. K., Delude, R. L. and McPherson, C. E. (1987). Characterization of genes which are deactivated upon the onset of development in Dictyostelium discoideum. Dev. Biol. 119, 433-441.[CrossRef][Medline]
Singleton, C. K., McPherson, C. E. and Manning, S. S. (1988). Deactivation of gene expression upon the onset of development in Dictyostelium discoideum. Dev. Genet. 9, 327-335.[CrossRef][Medline]
Singleton, C. K., Delude, R. L., Ken, R., Manning, S. S. and McPherson, C. E. (1991). Structure, expression, and regulation of members of the developmentally controlled V and H gene classes from Dictyostelium. Dev. Genet. 12, 88-97.[CrossRef][Medline]
Strmecki, L., Bloomfield, G., Araki, T., Dalton, E., Skelton, J., Schilde, C., Harwood, A., Williams, J. G., Ivens, A. and Pears, C. (2007). Proteomic and microarray analyses of the Dictyostelium Zak1-GSK-3 signaling pathway reveal a role in early development. Eukaryot. Cell 6, 245-252.
Swaminathan, G. and Tsygankov, A. Y. (2006). The Cbl family proteins: ring leaders in regulation of cell signaling. J. Cell Physiol. 209, 21-43.[CrossRef][Medline]
Theibert, A. and Devreotes, P. (1986). Surface receptor-mediated activation of adenylate cyclase in Dictyostelium: regulation by guanine nucleotides in wild-type cells and aggregation deficient mutants. J. Biol. Chem. 261, 15121-15125.
Thien, C. B. and Langdon, W. Y. (1997a). EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene. Oncogene 14, 2239-2249.[CrossRef][Medline]
Thien, C. B. and Langdon, W. Y. (1997b). Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Oncogene 15, 2909-2919.[CrossRef][Medline]
Thien, C. B. and Langdon, W. Y. (2001). Cbl: many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell. Biol. 2, 294-307.[CrossRef][Medline]
Thompson, C. R., Fu, Q., Buhay, C., Kay, R. R. and Shaulsky, G. (2004). A bZIP/bRLZ transcription factor required for DIF signaling in Dictyostelium. Development 131, 513-523.
Ueno, H., Sasaki, K., Miyagawa, K., Honda, H., Mitani, K., Yazaki, Y. and Hirai, H. (1997). Antisense repression of proto-oncogene c-Cbl enhances activation of the JAK-STAT pathway but not the ras pathway in epidermal growth factor receptor signaling. J. Biol. Chem. 272, 8739-8743.
Wang, L., Rudert, W. A., Loutaev, I., Roginskaya, V. and Corey, S. J. (2002). Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation. Oncogene 21, 5346-5355.[CrossRef][Medline]
Watts, D. J. and Ashworth, J. M. (1970). Growth of myxameobae of the cellular slime mould Dictyostelium discoideum in axenic culture. Biochem. J. 119, 171-174.[Medline]
Yoon, C. H., Lee, J., Jongeward, G. D. and Sternberg, P. W. (1995). Similarity of sli-1, a regulator of vulval development in C. elegans, to the mammalian proto-oncogene c-cbl. Science 269, 1102-1105.
Zhukovskaya, N. V., Fukuzawa, M., Yamada, Y., Araki, T. and Williams, J. G. (2006). The Dictyostelium bZIP transcription factor DimB regulates prestalk-specific gene expression. Development 133, 439-448.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
Related articles in JCS:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||